Therapeutic options for patients with congenital neutropenia include granulocyte-colony stimulating factor [G-CSF] to increase neutrophil counts and antimicrobials to manage infection.8 Whilst these treatments are standard of care to prevent neutropenia and infection, they often do not resolve intestinal inflammation.9–14. This evidence concerns the gene CSF3 and Decreased total neutrophil count.